The drug shortage crisis in Egypt has been resolved by 98%, Head of the Egyptian Drug Authority (EDA) Ali Ghamrawy announced during a press conference on February 3rd.

The Egyptian Drug Authority (EDA) has been successful in providing around 95% of unavailable medicines in the market so far, bringing the country closer to its pre-medicine shortage period, the authority’s head of Ali Al-Ghamrawy announced.

The ongoing drug shortage crisis in Egypt will be fully resolved within two months.

Egypt has provided 85% of the unavailable medicines so far.

The Egyptian Drug Authority (EDA) and the Unified Procurement Authority (UPA) have officially launched an initiative aimed at localizing the production of inactive raw materials to ensure the stability of drug supplies and bolster national drug security.

The Egyptian Drug Authority (EDA) has successfully resolved 75% of the ongoing medication shortage.

Prime Minister Mostafa Madbouly met with the Head of the Egyptian Drug Authority (EDA) Ali Ghamrawy to review a report on the availability of medicines in the Egyptian market.

This factsheet explores the current medication shortage in Egypt, providing an overview of the pharmaceutical industry’s key characteristics as well as its global and regional standing across various dimensions.

Egypt has allocated EGP 7 billion to ensure the rapid availability of essential medicines and medical supplies in hospitals and pharmacies.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) has received approval from the Egyptian Drug Authority (EDA) for price increases on all its major products.

The Egyptian government has committed to addressing the shortage of up to 3,000 types of medicine within three months, acknowledging that some drug prices will increase due to the devaluation of the local currency, Prime Minister Mostafa Madbouly stated in a press conference.

Prime Minister Mostafa Madbouly has announced a plan to adjust the prices of certain medicines in the market.

The Egyptian government has formed an advisory committee to review the prices of medicines every six months amid the current fluctuations in the Egyptian pound’s exchange rate against foreign currencies.

The Pharmaceutical Division at the Federation of Egyptian Chambers of Commerce will meet with representatives from the Egyptian Drugs Authority (EDA) next week to discuss the division's demands to increase drug prices in Egypt by up to 50%, the division’s head Ali Aouf told Arab Finance.

The Egyptian Drug Authority (EDA) and Jordan Food and Drug Administration (JFDA) have probed joint cooperation in the pharmaceutical sector.

The prices of around 2,000 medicines have increased by 15% since January 2023 until mid-August, Chairman of the Drug Division of Egypt’s Federation of Egyptian Chambers of Commerce Ali Ouf said.